162 related articles for article (PubMed ID: 21072897)
1. MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells.
Sakuraoka Y; Sawada T; Okada T; Shiraki T; Miura Y; Hiraishi K; Ohsawa T; Adachi M; Takino J; Takeuchi M; Kubota K
World J Gastroenterol; 2010 Nov; 16(42):5334-41. PubMed ID: 21072897
[TBL] [Abstract][Full Text] [Related]
2. Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression.
Takino J; Yamagishi S; Takeuchi M
World J Gastroenterol; 2012 Apr; 18(15):1781-8. PubMed ID: 22553402
[TBL] [Abstract][Full Text] [Related]
3. A novel anti-cancer substance, MK615, from ume, a variety of Japanese apricot, inhibits growth of hepatocellular carcinoma cells by suppressing Aurora A kinase activity.
Okada T; Sawada T; Osawa T; Adachi M; Kubota K
Hepatogastroenterology; 2007 Sep; 54(78):1770-4. PubMed ID: 18019715
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms.
Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL
Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443
[TBL] [Abstract][Full Text] [Related]
5. The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.
Takino J; Kobayashi Y; Takeuchi M
J Gastroenterol; 2010 Jun; 45(6):646-55. PubMed ID: 20084527
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products.
Maeda S; Matsui T; Ojima A; Takeuchi M; Yamagishi S
Nutr Res; 2014 Sep; 34(9):807-13. PubMed ID: 25241332
[TBL] [Abstract][Full Text] [Related]
7. Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction.
Sotokawauchi A; Nakamura N; Matsui T; Higashimoto Y; Yamagishi SI
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283652
[TBL] [Abstract][Full Text] [Related]
8. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
[TBL] [Abstract][Full Text] [Related]
9. The Role of receptor for Advanced Glycation End Products (RAGE) in the proliferation of hepatocellular carcinoma.
Yaser AM; Huang Y; Zhou RR; Hu GS; Xiao MF; Huang ZB; Duan CJ; Tian W; Tang DL; Fan XG
Int J Mol Sci; 2012; 13(5):5982-5997. PubMed ID: 22754344
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
Takeuchi M; Yamagishi S
Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy.
Takeuchi M; Takino J; Yamagishi S
Curr Drug Targets; 2010 Nov; 11(11):1468-82. PubMed ID: 20583971
[TBL] [Abstract][Full Text] [Related]
12. The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs.
Xue J; Ray R; Singer D; Böhme D; Burz DS; Rai V; Hoffmann R; Shekhtman A
Biochemistry; 2014 May; 53(20):3327-35. PubMed ID: 24824951
[TBL] [Abstract][Full Text] [Related]
13. Role of the receptor for advanced glycation end products in hepatic fibrosis.
Lohwasser C; Neureiter D; Popov Y; Bauer M; Schuppan D
World J Gastroenterol; 2009 Dec; 15(46):5789-98. PubMed ID: 19998499
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
[TBL] [Abstract][Full Text] [Related]
15. Osteomeles schwerinae extracts inhibits the binding to receptors of advanced glycation end products and TGF-β1 expression in mesangial cells under diabetic conditions.
Kim YS; Jung DH; Lee IS; Pyun BJ; Kim JS
Phytomedicine; 2016 Apr; 23(4):388-97. PubMed ID: 27002409
[TBL] [Abstract][Full Text] [Related]
16. MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases.
Okada T; Sawada T; Osawa T; Adachi M; Kubota K
World J Gastroenterol; 2008 Mar; 14(9):1378-82. PubMed ID: 18322951
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
18. New anti-proliferative agent, MK615, from Japanese apricot "Prunus mume" induces striking autophagy in colon cancer cells in vitro.
Mori S; Sawada T; Okada T; Ohsawa T; Adachi M; Keiichi K
World J Gastroenterol; 2007 Dec; 13(48):6512-7. PubMed ID: 18161921
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gammaactivation.
Yamagishi S; Matsui T; Nakamura K; Takeuchi M; Inoue H
Protein Pept Lett; 2008; 15(8):850-3. PubMed ID: 18855759
[TBL] [Abstract][Full Text] [Related]
20. A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC.
Hiwatashi K; Ueno S; Abeyama K; Kubo F; Sakoda M; Maruyama I; Hamanoue M; Natsugoe S; Aikou T
Ann Surg Oncol; 2008 Mar; 15(3):923-33. PubMed ID: 18080716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
